Capital Research Global Investors Amends Celanese Stake

Ticker: CE · Form: SC 13G/A · Filed: 2024-02-09T00:00:00.000Z

Sentiment: neutral

Topics: institutional-ownership, amendment, passive-investing

TL;DR

**Capital Research Global Investors updated their Celanese Corp. holdings, signaling a change in their significant passive stake.**

AI Summary

Capital Research Global Investors, a major investment firm, filed an amended SC 13G/A on February 9, 2024, indicating a change in their ownership of Celanese Corp. common stock as of December 29, 2023. This filing, an amendment to a previous disclosure, signals that Capital Research Global Investors continues to hold a significant, though potentially altered, passive stake in Celanese. For investors, this matters because large institutional holdings can influence stock stability and signal confidence (or lack thereof) in the company's future prospects.

Why It Matters

This filing shows a prominent institutional investor's updated position in Celanese, which can impact market perception and trading activity for the stock.

Risk Assessment

Risk Level: low — This is a routine amendment filing by a passive institutional investor, indicating no immediate high-risk events.

Analyst Insight

Investors should note that a major institutional investor is adjusting its position in Celanese, which could be a signal to review their own holdings, though the specific nature of the change (increase or decrease) is not detailed in this excerpt.

Key Players & Entities

Forward-Looking Statements

FAQ

What type of filing is this document?

This document is an SC 13G/A, which is an amendment to a Schedule 13G filing under the Securities Exchange Act of 1934, specifically filed under Rule 13d-1(b).

Who is the reporting person in this filing?

The reporting person is Capital Research Global Investors, with IRS Identification No. 95-1411037 and organized in Delaware.

What company's securities are being reported on?

The securities being reported on are the Common Stock of Celanese Corp., which has a CUSIP Number of 150870103.

What was the 'Date of Event Which Requires Filing of this Statement'?

The date of the event which requires the filing of this statement was December 29, 2023.

What is the business address of Capital Research Global Investors?

The business address for Capital Research Global Investors is 333 South Hope Street, 55th FL, Los Angeles, CA 90071.

From the Filing

0001422848-24-000062.txt : 20240209 0001422848-24-000062.hdr.sgml : 20240209 20240209174633 ACCESSION NUMBER: 0001422848-24-000062 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240209 DATE AS OF CHANGE: 20240209 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Celanese Corp CENTRAL INDEX KEY: 0001306830 STANDARD INDUSTRIAL CLASSIFICATION: PLASTIC MATERIAL, SYNTH RESIN/RUBBER, CELLULOS (NO GLASS) [2820] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 980420726 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-80386 FILM NUMBER: 24616466 BUSINESS ADDRESS: STREET 1: 222 W. LAS COLINAS BLVD., SUITE 900N CITY: IRVING STATE: TX ZIP: 75039-5421 BUSINESS PHONE: 972-443-4000 MAIL ADDRESS: STREET 1: 222 W. LAS COLINAS BLVD., SUITE 900N CITY: IRVING STATE: TX ZIP: 75039-5421 FORMER COMPANY: FORMER CONFORMED NAME: Celanese CORP DATE OF NAME CHANGE: 20041102 FORMER COMPANY: FORMER CONFORMED NAME: Blackstone Crystal Holdings Capital Partners (Cayman) IV Ltd. DATE OF NAME CHANGE: 20041022 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Capital Research Global Investors CENTRAL INDEX KEY: 0001422848 ORGANIZATION NAME: IRS NUMBER: 951411037 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 333 SOUTH HOPE STREET STREET 2: 55TH FL CITY: LOS ANGELES STATE: CA ZIP: 90071 BUSINESS PHONE: 213-486-9200 MAIL ADDRESS: STREET 1: 333 SOUTH HOPE STREET STREET 2: 55TH FL CITY: LOS ANGELES STATE: CA ZIP: 90071 SC 13G/A 1 SEC13G_Filing.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 ) * Celanese Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 150870103 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes.) CUSIP No. 150870103 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Capital Research Global Investors 95-1411037 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 14,807,442 6. SHARED VOTING POWER 0 7. SOLE DISPOSITIVE POWER 14,809,178 8. SHARED DISPOSITIVE POWER 0 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 14,809,178 Beneficial ownership disclaimed pursuant to Rule 13d-4 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 13.6% 12. TYPE OF REPORTING PERSON IA Item 1. (a) Name of Issuer Celanese Corp. (b) Address of Issuer's Principal Executive Offices 222 West Las Colinas Boulevard, Ste 900N, Irving, TX 75039-5421 Item 2. (a) Name of Person Filing Capital Research Global Investors (b) Address of Principal Business Office or, if None, Residence 333 South Hope Street, 55th Fl, Los Angeles, CA 90071 (c) Citizenship N/A (d) Title of Class of Securities Common Stock (e) CUSIP Number 150870103 Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2

View on Read The Filing